| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 1593750
[patent_doc_number] => 06383734
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-05-07
[patent_title] => 'Method to determine inhibition of PAK3 activation of Raf-1'
[patent_app_type] => B1
[patent_app_number] => 09/163507
[patent_app_country] => US
[patent_app_date] => 1998-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 16
[patent_no_of_words] => 9958
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/383/06383734.pdf
[firstpage_image] =>[orig_patent_app_number] => 09163507
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/163507 | Method to determine inhibition of PAK3 activation of Raf-1 | Sep 29, 1998 | Issued |
| 09/150684 | NUCLEOTIDE SEQUENCES AND AMINO ACID SEQUENCES OF SECRETED PROTEINS INVOLVED IN ANGIOGENESIS | Sep 9, 1998 | Abandoned |
Array
(
[id] => 1602450
[patent_doc_number] => 06432628
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-08-13
[patent_title] => 'Caspase-14, an apoptotic protease, nucleic acids encoding and methods of use'
[patent_app_type] => B1
[patent_app_number] => 09/139600
[patent_app_country] => US
[patent_app_date] => 1998-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 11
[patent_no_of_words] => 20626
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 151
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/432/06432628.pdf
[firstpage_image] =>[orig_patent_app_number] => 09139600
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/139600 | Caspase-14, an apoptotic protease, nucleic acids encoding and methods of use | Aug 24, 1998 | Issued |
Array
(
[id] => 6642730
[patent_doc_number] => 20030103987
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-05
[patent_title] => 'METHOD OF INACTIVATION OF RAS SUBFAMILY PROTEINS AND AGENTS THEREFOR'
[patent_app_type] => new
[patent_app_number] => 09/126816
[patent_app_country] => US
[patent_app_date] => 1998-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 11400
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0103/20030103987.pdf
[firstpage_image] =>[orig_patent_app_number] => 09126816
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/126816 | Agents useful for inactivation of Ras subfamily proteins | Jul 30, 1998 | Issued |
Array
(
[id] => 4306784
[patent_doc_number] => 06252051
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-06-26
[patent_title] => 'ErbB4 receptor-specific neuregulin related ligand antibodies and uses therefor'
[patent_app_type] => 1
[patent_app_number] => 9/126121
[patent_app_country] => US
[patent_app_date] => 1998-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 17
[patent_no_of_words] => 39847
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/252/06252051.pdf
[firstpage_image] =>[orig_patent_app_number] => 126121
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/126121 | ErbB4 receptor-specific neuregulin related ligand antibodies and uses therefor | Jul 29, 1998 | Issued |
Array
(
[id] => 1484684
[patent_doc_number] => 06365348
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-04-02
[patent_title] => 'Compounds for diagnosis of Breast cancer and methods for their use'
[patent_app_type] => B1
[patent_app_number] => 09/118554
[patent_app_country] => US
[patent_app_date] => 1998-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14100
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/365/06365348.pdf
[firstpage_image] =>[orig_patent_app_number] => 09118554
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/118554 | Compounds for diagnosis of Breast cancer and methods for their use | Jul 16, 1998 | Issued |
Array
(
[id] => 1043797
[patent_doc_number] => 06867231
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-03-15
[patent_title] => 'Therapeutic systems'
[patent_app_type] => utility
[patent_app_number] => 09/445865
[patent_app_country] => US
[patent_app_date] => 1998-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 21
[patent_no_of_words] => 20136
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/867/06867231.pdf
[firstpage_image] =>[orig_patent_app_number] => 09445865
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/445865 | Therapeutic systems | Jun 14, 1998 | Issued |
Array
(
[id] => 6047709
[patent_doc_number] => 20020168679
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-11-14
[patent_title] => 'STAINING AGENTS AND PROTOCOLS FOR CHARACTERIZING MALIGNANT CELLS IN CULTURE'
[patent_app_type] => new
[patent_app_number] => 09/095993
[patent_app_country] => US
[patent_app_date] => 1998-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5799
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0168/20020168679.pdf
[firstpage_image] =>[orig_patent_app_number] => 09095993
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/095993 | STAINING AGENTS AND PROTOCOLS FOR CHARACTERIZING MALIGNANT CELLS IN CULTURE | Jun 10, 1998 | Abandoned |
Array
(
[id] => 6262517
[patent_doc_number] => 20020188114
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-12-12
[patent_title] => 'REAGENTS AND METHODS USEFUL FOR DETECTINGS DISEASES OF THE LUNG'
[patent_app_type] => new
[patent_app_number] => 09/092296
[patent_app_country] => US
[patent_app_date] => 1998-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 38699
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0188/20020188114.pdf
[firstpage_image] =>[orig_patent_app_number] => 09092296
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/092296 | REAGENTS AND METHODS USEFUL FOR DETECTINGS DISEASES OF THE LUNG | Jun 4, 1998 | Abandoned |
Array
(
[id] => 1504723
[patent_doc_number] => 06465623
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2002-10-15
[patent_title] => 'GDU, a novel signalling protein'
[patent_app_type] => B2
[patent_app_number] => 08/945771
[patent_app_country] => US
[patent_app_date] => 1998-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 3175
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 869
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/465/06465623.pdf
[firstpage_image] =>[orig_patent_app_number] => 08945771
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/945771 | GDU, a novel signalling protein | Apr 21, 1998 | Issued |
Array
(
[id] => 4398735
[patent_doc_number] => 06297364
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-10-02
[patent_title] => 'Isolated nucleic acid molecule encoding cancer associated antigen, the antigen itself, and uses thereof'
[patent_app_type] => 1
[patent_app_number] => 9/061709
[patent_app_country] => US
[patent_app_date] => 1998-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7944
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/297/06297364.pdf
[firstpage_image] =>[orig_patent_app_number] => 061709
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/061709 | Isolated nucleic acid molecule encoding cancer associated antigen, the antigen itself, and uses thereof | Apr 16, 1998 | Issued |
| 09/046737 | ENDOSTATIN DERIVED NOVEL PEPTIDES WITH ANTI-ANGIOGENIC AND ANTI-CANCER ACTIVITY | Mar 23, 1998 | Abandoned |
Array
(
[id] => 528208
[patent_doc_number] => 07183401
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2007-02-27
[patent_title] => 'NOEY2 gene compositions and methods of use'
[patent_app_type] => utility
[patent_app_number] => 10/166325
[patent_app_country] => US
[patent_app_date] => 1998-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 18
[patent_no_of_words] => 55014
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/183/07183401.pdf
[firstpage_image] =>[orig_patent_app_number] => 10166325
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/166325 | NOEY2 gene compositions and methods of use | Mar 19, 1998 | Issued |
Array
(
[id] => 4314680
[patent_doc_number] => 06316599
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-11-13
[patent_title] => 'Localization and characterization of the Wilms\' tumor gene'
[patent_app_type] => 1
[patent_app_number] => 9/037179
[patent_app_country] => US
[patent_app_date] => 1998-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 22
[patent_no_of_words] => 19481
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/316/06316599.pdf
[firstpage_image] =>[orig_patent_app_number] => 037179
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/037179 | Localization and characterization of the Wilms' tumor gene | Mar 8, 1998 | Issued |
| 09/036724 | ACTIVE IMMUNIZATION AGAINST ANGIOGENESIS-ASSOCIATED ANTIGENS | Mar 5, 1998 | Abandoned |
Array
(
[id] => 1560814
[patent_doc_number] => 06437113
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-08-20
[patent_title] => 'Suppressors of death domains'
[patent_app_type] => B1
[patent_app_number] => 09/035676
[patent_app_country] => US
[patent_app_date] => 1998-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5568
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/437/06437113.pdf
[firstpage_image] =>[orig_patent_app_number] => 09035676
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/035676 | Suppressors of death domains | Mar 4, 1998 | Issued |
Array
(
[id] => 1416633
[patent_doc_number] => 06514712
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-02-04
[patent_title] => 'Probe for the early detection of displasias in multilayer tesselated epithelium and for the diagnosis and therapy of carcinomas'
[patent_app_type] => B1
[patent_app_number] => 08/930830
[patent_app_country] => US
[patent_app_date] => 1998-01-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 9
[patent_no_of_words] => 10568
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/514/06514712.pdf
[firstpage_image] =>[orig_patent_app_number] => 08930830
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/930830 | Probe for the early detection of displasias in multilayer tesselated epithelium and for the diagnosis and therapy of carcinomas | Jan 15, 1998 | Issued |
Array
(
[id] => 1517961
[patent_doc_number] => 06500937
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-12-31
[patent_title] => 'Nucleotide sequence encoding a mammary cell growth inhibitor'
[patent_app_type] => B1
[patent_app_number] => 08/994076
[patent_app_country] => US
[patent_app_date] => 1997-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 21
[patent_no_of_words] => 17154
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/500/06500937.pdf
[firstpage_image] =>[orig_patent_app_number] => 08994076
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/994076 | Nucleotide sequence encoding a mammary cell growth inhibitor | Dec 18, 1997 | Issued |
| 08/933359 | SYNERGISTIC COMPOSITION AND METHODS FOR TREATINGNEOPLASTIC OR CANCEROUS GROWTHS AND FOR RESTORING OR BOOSTING HEMATOPOIESIS | Sep 17, 1997 | Abandoned |
Array
(
[id] => 4240576
[patent_doc_number] => 06136311
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-10-24
[patent_title] => 'Treatment and diagnosis of cancer'
[patent_app_type] => 1
[patent_app_number] => 8/895914
[patent_app_country] => US
[patent_app_date] => 1997-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 17
[patent_no_of_words] => 15896
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 112
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/136/06136311.pdf
[firstpage_image] =>[orig_patent_app_number] => 895914
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/895914 | Treatment and diagnosis of cancer | Jul 16, 1997 | Issued |